MoneyWorks4Me

Medicamen Biotech - Quaterly Results

03 Nov 2021 Evaluate
The revenue zoomed 5.68% to Rs. 325.20 millions for the quarter ended September 2021 as compared to Rs. 307.72 millions during the corresponding quarter last year.A good growth in profit of 30.96% reported to Rs. 42.22  millions over Rs. 32.24 millions of corresponding previous quarter.Operating profit surged to 67.03 millions from the corresponding previous quarter of 56.77 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 325.20 307.72 5.68 600.50 568.87 5.56 1101.46 1173.42 -6.13
Other Income 4.76 1.32 260.61 5.55 2.16 156.94 7.54 19.09 -60.50
PBIDT 67.03 56.77 18.07 128.22 96.62 32.71 203.35 196.71 3.38
Interest 3.00 3.78 -20.63 3.44 6.18 -44.34 10.64 5.68 87.32
PBDT 64.03 52.99 20.83 124.78 90.44 37.97 192.71 191.03 0.88
Depreciation 13.50 6.99 93.13 26.80 13.91 92.67 25.20 24.99 0.84
PBT 50.53 46.00 9.85 97.98 76.53 28.03 167.51 166.04 0.89
TAX 8.31 13.76 -39.61 14.25 23.24 -38.68 42.65 43.45 -1.84
Deferred Tax -3.99 0.16 -2593.75 -4.65 0.41 -1234.15 1.19 -2.50 -147.60
PAT 42.22 32.24 30.96 83.73 53.29 57.12 124.86 122.59 1.85
Equity 122.17 122.17 0.00 122.17 122.17 0.00 122.17 122.17 0.00
PBIDTM(%) 20.61 18.45 11.73 21.35 16.98 25.72 18.46 16.76 10.13
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..